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Background: The assessment of functioning and disability is an important part of the clinical evaluation, since it
measures disease burden and reflects the effectiveness of therapeutic planning and interventions. The aim of the
current study was to develop such a self-report instrument on the basis of a review of the literature, and
compatible with the WHO approach.
Material and methods: The review of the literature led to the development of the Global Disability Scale (Glo.Di.S)
with 25 items assessing different aspects of disability. The study sample included 728 persons from vulnerable
populations (homeless, jobless, very low income, single parent families etc.; (29.12% males and 70.88% females;
aged 55.96 ± 15.22 years). The protocol included also the STAI and the CES-D. The statistical analysis included
factor analysis item analysis and ANCOVA.
Results: The factor analysis revealed the presence of 4 factors explaining 71% of total variance (Everyday
functioning, Social and interpersonal functioning, Severity and Mental disability). Chronbach’s alpha for the whole
scale was 0.95 and for subscales were 0.74–0.94.
Discussion: The results of the current study suggest that the Glo.Di.S. has the potential to serve as a reliable and
valid tool for assessing functioning and disability. Further research is needed to prove that it could be useful across
countries, populations and diseases, and whether it provides data that are culturally meaningful and comparable.
It can be used in surveys and in clinical research settings and it can generate information of use in evaluating
health needs and the effectiveness of interventions to reduce disability and improve health.
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During the last few decades, the assessment of function-
ing and disability became important and part of the clin-
ical evaluation, since it shows the ability of an individual
to function in general areas of life. Along with mortality,
morbidity and other rates reflecting a population’s health
status, disability is important in order to measure disease
burden and to evaluate the effectiveness of therapeutic
planning and interventions. The description of clinical
symptoms and their response to treatment alone does
not seem to be sufficient for the comprehensive under-
standing of the disease and the needs of the patients.* Correspondence: kfount@med.auth.gr
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distribution, and reproduction in any mediumThe addition of the assessment of disability enhances pa-
tient management, intervention design and the reporting
of health [1].
The literature strongly suggests that symptom severity
does not always correlate strongly with disability and
only specific domains of the clinical picture seem to
be responsible for the observed functional impairment.
It is also reported that only a small proportion of the
observed variability for disability is explained by any
combination of clinical symptoms [2-8].
However, in spite of recommendations, this assessment
has not yet become part of routine every day clinical
practice. This is partially because defining and measuring
disability has always been a challenge. In clinical practice
it is a challenge both in terms of skills and time consum-
ing to assess the individual patients’ broad spectrum of
problems precisely, and areas like life satisfaction, qualityentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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viewers [9].
In order to address this challenge, several instruments
have been developed so far and a huge number of con-
cepts and definitions have been developed and operatio-
nalized [10].
The World Health Organization (WHO) established
the International Classification of Functioning, Disability
and Health (ICF) [11]. The joint use of the ICD-10 [12]
and the ICF serves this purpose [1]. The WHO also
developed a standard instrument the World Health
Organization Disability Assessment Schedule (WHO-
DAS) [13]. The WHODAS captures an individual’s level
of functioning in six major life domains: (i) cognition
(understanding and communication); (ii) mobility (ability
to move and get around); (iii) self-care (ability to attend
to personal hygiene, dressing and eating, and to live
alone); (iv) getting along (ability to interact with other
people); (v) life activities (ability to carry out responsibil-
ities at home, work and school); (vi) participation in
society (ability to engage in community, civil and recre-
ational activities).
It is true that existing disability measures in psychiatry
are either comprehensive but lengthy, or too short and
uni-dimentional. There is a need for a user friendly, rela-
tively short but comprehensive, simple, cost-effective,
and sensitive measure of disability and functional impair-
ment in clinical practice. The aim of the current study
was to develop such a self-report instrument on the basis
of a systematic review of the literature, and compatible
with the WHO approach.
Material and methods
Development of the scale
The first step was to review the literature and indentify
scales assessing disability. The MEDLINE search
returned 104 articles relevant for the current study. The
review led to the development of 25 items assessing dif-
ferent aspects of disability. They comprised the Global
Disability Scale (Glo.Di.S). It is essential to report that
the WHODAS [13] and its content were extremely influ-
ential in the development of this scale.
The scoring method was developed after consensus by
three of the researchers (KNF, AD and NM) and it was
assumed that a mentally and physically healthy person
aged below 50 would receive a score close to zero in all
items of the scale. The scoring method included four
options as response to each item (0 = not at all, 1 = a lit-
tle, 2 =moderately, 3 = severely and 4 = very severe or
complete disability). The Glo.Di.S scale and its subscales
are shown in the Additional file 1.
The gathering of the data was done by four trained
psychologists with the use of an internet-based elec-
tronic platform. In this frame, although he Glo.Di.S wasdeveloped as a self-report tool, for the particular study
the questions were read by the interviewer and the sub-
ject was choosing the right answer as it is was a strict
structured interview with no input at all from the side of
the interviewer.
The study was approved by the Ethics Committee of
the Aristotle University Medical School. All subjects
gave their informed consent. All procedures were
approved by the National Authority for the protection of
personal and private data.
Study population
In the frame of a study on vulnerable populations
(homeless, jobless, very low income, single parent fam-
ilies etc.) sponsored by the Municipality of Thessaloniki
Greece, these items were applied to 728 subjects from
this particular population (29.12% males and 70.88%
females) aged 55.96 ± 15.22 (range 19–94 years).
Psychometric assessment
Apart from demographic variables, the protocol included
the registration of health status with codes for the major
disease categories according to the ICD-10 [12] and the
World Health Organization. It also registered height and
weight, details about current and past occupational sta-
tus and alcohol and drug use and abuse. Anxiety was
assessed with the STAI [14] and depression with the
CES-D [15]. The test-retest reliability was not studied. It
is also important to note that the collection of the data
has been completed by 2009, that is, essentially before
the current economic crisis really began.
Statistical analysis
The analysis included the development of descriptive stat-
istic tables for the study sample, and specifically frequency
tables for each reply in each item of the new scale.
The statistical analysis included factor analysis with
Varimax normalized rotation, item analysis and the
calculation of Cronbach’s alpha, and the calculation
of Pearson Product moment correlation coefficient
between the new scale and age, BMI, STAI-S, STAI-T
and CES-D. The Analysis of Covariate (ANCOVA) was
also performed with total Glo.Di.S. score and subscales
scores as dependent variables, sex as categorical pre-
dictor and age, BMI, STAI-S and T and CES-D scores as
continues predictors.
Results
The frequencies and mean scores for each of the scale
items are shown in Table 1. The factor analysis revealed
the presence of 4 factors explaining 71% of total vari-
ance. The first one included items 1–10, 16 and 21,
the second included 17–20 and 22, the third included 1,
11–13, 21 and 23–25 while the fourth included 8, 14–16,
Table 1 Frequency of responses and mean score in the various items and subscales of the Glo.Di.S
Item
no.
Item Frequency of responses Score
0 1 2 3 4 mean SD
1 Stand up from sitting 70.76 10.76 9.38 6.34 2.76 0.60 1.07
2 Dress by yourself 91.60 2.20 2.89 2.07 1.24 0.19 0.70
3 Eat by yourself 96.69 1.24 0.41 0.97 0.69 0.08 0.47
4 Move around your house by yourself 87.72 4.97 2.76 3.31 1.24 0.25 0.77
5 Take a bath or a shower by yourself 87.05 3.72 3.03 4.27 1.93 0.30 0.87
6 Carryout the most important works in the house 75.59 9.52 6.07 6.21 2.62 0.51 1.03
7 Complete all the works of the house 74.90 8.83 6.90 6.62 2.76 0.54 1.06
8 Carry on your everyday work 77.76 5.94 5.25 8.29 2.76 0.52 1.09
9 Stay alone for a few days 78.65 4.82 5.10 7.44 3.99 0.53 1.13
10 Get out of the house for a walk, shopping etc. 81.40 5.65 4.41 5.79 2.75 0.43 1.01
11 Deal with various obstacles or physically demanding situations
(stairs, taking the bus etc.)
53.52 14.48 9.24 17.66 5.10 1.06 1.34
12 Stand for some time (15–30 minutes) 58.26 10.19 8.40 16.12 7.02 1.03 1.39
13 Walk for a distance of around a kilometer 58.34 9.38 7.72 16.14 8.41 1.07 1.44
14 Concentrate on something for 5–10 minutes (Newspaper, TV, cooking) 88.57 4.55 3.44 3.17 0.28 0.22 0.68
15 Learn something new (how to go to a new place, a new recipe etc) 83.03 4.97 3.59 6.76 1.66 0.39 0.96
16 Participate in the activities of the community (e.g. religious, celebrations etc.) 80.80 4.42 5.52 7.73 1.52 0.45 1.00
17 Handle your relationships with people close to you (friends, relatives etc.) 84.00 4.69 6.07 4.55 0.69 0.33 0.84
18 Socialize with people you don’t know 86.60 4.56 5.11 3.59 0.14 0.26 0.73
19 Keep a friendship 87.02 4.42 4.56 4.01 0.00 0.26 0.72
20 Make new friends 81.24 4.83 5.66 8.00 0.28 0.41 0.93
21 Have sexual life 75.21 2.62 3.99 12.12 6.06 0.71 1.32
22 Live with dignity because of your problem 73.76 6.49 5.80 12.85 1.10 0.61 1.12
23 How much time you dedicated to your health issues and their consequences? 60.33 11.43 9.78 17.36 1.10 0.87 1.22
24 How emotionally distressed are you because of your health? 56.14 7.59 10.76 22.07 3.45 1.09 1.36
25 How much of an economic burden to you and your family is your health? 69.15 7.85 8.82 12.40 1.79 0.70 1.16
Everyday functioning




Fountoulakis et al. Annals of General Psychiatry 2012, 11:14 Page 3 of 7
http://www.annals-general-psychiatry.com/content/11/1/1418 and 21. Items 1, 8, 16 and 18 loaded almost equally in
two factors, while item 21 (sexual life) loaded in three
factors (Table 2). Secondary factor analysis revealed a
single secondary factor structure.
These four factors correspond to four subscales. The
first one is ‘everyday functioning’. The second corre-
sponds to ‘Social and interpersonal functioning’, the third
to ‘severity’ and the fourth to ‘mental disability’. The
mean scores for each of the subscales as well as the
mean total score are shown in Table 1.
Chronbach’s alpha for the whole scale was 0.95 and for
subscales were 0.94, 0.74, 0.92 and 0.75 respectively.
The ANCOVA suggested no differences between males
and females. However age, BMI and CES-D score were
significantly correlated with disability. The correlationmatrix between the new scale and age, BMI, STAI-S,
STAI-T and CES-D is shown in Table 3.
Discussion
The current paper reports the preliminary results from
the development of the Global Disability Scale (Glo.Di.S).
This scale is a 25-items user friendly self report instru-
ment which assesses disability in accord with the ICF
approach of the WHO. It manifests high internal reliabil-
ity (0.95) and consists of four subscales (Everyday func-
tioning, Social and interpersonal functioning, Severity and
Mental disability).
In comparison, the WHODAS-II has a mean Cron-
bach’s alpha equal to 0.65–0.98 [16-25], test-retest coef-
ficients from 0.71–0.96 [19,23,25,26] and inter-rater
Table 2 Factor analysis
Glo.Di.S item Factor 1 Factor 2 Factor 3 Factor 4
Stand up from sitting 0.57 0.11 0.63 0.23
Dress by yourself 0.84 0.14 0.25 0.10
Eat by yourself 0.73 0.31 -0.05 -0.15
Move around your house by yourself 0.81 0.12 0.32 0.21
Take a bath or a shower by yourself 0.80 0.13 0.31 0.25
Carryout the most important works in the house 0.70 0.14 0.40 0.45
Complete all the works of the house 0.65 0.11 0.45 0.44
Carry on your everyday work 0.54 0.28 0.37 0.50
Stay alone for a few days 0.54 0.21 0.31 0.22
Get out of the house for a walk, shopping etc. 0.68 0.08 0.47 0.37
Deal with various obstacles or physically demanding situations
(stairs, taking the bus etc.)
0.29 0.14 0.83 0.08
Stand for some time (15–30 minutes) 0.28 0.15 0.85 0.13
Walk for a distance of around a kilometer 0.27 0.13 0.85 0.13
Concentrate on something for 5–10 minutes (Newspaper, TV, cooking) 0.09 0.27 0.17 0.73
Learn something new (how to go to a new place, a new recipe etc) 0.26 0.33 0.17 0.64
Participate in the activities of the community (e.g. religious, celebrations etc.) 0.43 0.34 0.39 0.54
Handle your relationships with people close to you (friends, relatives etc.) 0.18 0.64 0.20 0.21
Socialize with people you don’t know 0.26 0.66 0.10 0.51
Keep a friendship 0.20 0.82 0.09 0.25
Make new friends 0.05 0.84 0.13 0.23
Have sexual life 0.44 0.24 0.37 0.39
Live with dignity because of your problem 0.18 0.48 0.38 -0.11
How much time you dedicated to your health issues and their consequences? 0.20 0.25 0.69 0.38
How emotionally distressed are you because of your health? 0.13 0.33 0.66 0.39
How much of an economic burden to you and your family is your health? 0.34 0.03 0.55 0.42
Explained variance 5.85 3.36 5.38 3.35
Proportion of variance explained 23% 13% 22% 13%
Total variance explained 71%
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[20,21,25]. The short version might represent a single
factor [27,28]. The large version consists probably of 6
subscales (understanding and communicating, getting
around, self-care, getting along with people, life activities
and participation in society) and a single superfactor
(a two-factor solution is also possible) [19,24].
The screener part of the ICF Measure of Participation










All values significant at p< 0.05 are marked in bold italics underlined.9 scales, reflecting the 9 activity and participation chap-
ters of the ICF. Again the Chronbach’s alpha was satisfy-
ing for all 9 domains (0.75–0.89) and excellent for the
total score (0.96). The test-retest reliability was good at
item level (0.44–0.72), domain level (0.72–0.92) and total
score (0.94) [29]. The Lam Employment Absence and
Productivity Scale (LEAPS), which is a 10-item self-
report questionnaire has a Cronbach’s alpha of 0.89 [30].
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bach’s alpha >0.70 [31-33,35]. The test-retest reliability
was 0.73 [33].
The Glo.Di.S manifests psychometric properties simi-
lar to the WHODAS and maybe superior to the other
scales in terms of internal consistency.
The above instruments have already been used in
the study of disability across a number of sociodemo-
graphic variables and different diseases and disorders,
including acne vulgaris with social phobia [36], bipolar
disorder [37-39], undifferentiated peripheral inflamma-
tory arthritis [40], adult-onset hearing loss [41], psych-
otic disorders [42-47], multiple sclerosis [47], depression
and anxiety [7,46,48-60], injury [61-63], alcohol abuse
[64], sex differences [53,65-67], arthritis [60], chronic
spinal pain [60], high blood pressure [60], social anxiety
[68], obsessive-compulsive disorder [69], on-pump cor-
onary artery bypass [70], dementia [71], cancer with
pain [72,73], obesity and type 2 diabetes mellitus [74],
mental-physical disorders comorbidity [75,76], leprosy [77],
ADHD [78,79], anxiety in children [80], Parkinson’s
disease [81], macular degeneration [48], inflammatory
arthritis [23], migraine [8] and systemic sclerosis
[82,83].
All scales manifest a number of similar drawbacks. All
of them fail to tackle specific aspects of disability. The
WHODAS covers mainly the activities and participation
domains of the ICF, so bodily impairments and environ-
mental factors are not included. The SDS has similar
limitations and is often inadequate to discern subtle, but
important changes which may occur between measure-
ments [84].
The Glo.Di.S. was developed in order to constitute
a short, easy to use scale for the assessment of global
disability and impairment. Its development aimed at
constructing an instrument which would not mix func-
tioning with symptomatology or subjective feelings and
preferences. Instead the Glo.Di.S covers a broad area
of disability and impairment and can be used in a variety
of diseases including psychiatric disorders. Its structure
will allow the comparison between disorders in an
objective way.
Conclusion
The results of the current study suggest that the Glo.Di.
S. has the potential to serve as a reliable and valid tool
for assessing functioning and disability. Further research
is needed to prove that it could be useful across coun-
tries, populations and diseases, and whether it provides
data that are culturally meaningful and comparable. It
can be used in surveys and in clinical research settings
and it can generate information of use in evaluating
health needs and the effectiveness of interventions to
reduce disability and improve health.Additional file
Additional file 1: Global Disability Scale (Glo.Di.S).
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